Literature DB >> 3852778

Different allotypes of C3 degrade at different rates.

P H Kay, S Natsuume-Sakai, J Hayakawa, R L Dawkins.   

Abstract

To determine whether different forms of C3 degrade at different rates, we compared two strains of mice with a B10 background. The only difference was that one is C3A, while the other is C3B. These strains allow comparison of C3A and C3B without the added complication of differing C3 convertases. Sera from the two strains were incubated with zymosan and the degradation products were detected by immunofixation following electrophoresis in agarose. The rate of degradation of mouse C3B was more rapid than that of C3A. Differences in the rates of degradation could not be explained by differing concentrations of C3. We suggest that the genetic differences in C3 determine the decay rate following activation via the alternate pathway.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3852778     DOI: 10.1007/bf00430304

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  21 in total

1.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

2.  Capacity of complement c3 phenotypes to bind on to mononuclear cells in man.

Authors:  H Arvilommi
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

3.  Studies of the C3 polymorphism. Rlationship between C3 phenotypes and rheumatoid arthritis.

Authors:  R Brönnestam
Journal:  Hum Hered       Date:  1973       Impact factor: 0.444

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17.

Authors:  S Natsuume-Sakai; J I Hayakawa; M Takahashi
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

7.  Quantitative estimation of serum Ss level: changes upon the development of autoantibodies, environment and acute inflammation in inbred mice.

Authors:  S Natsuume-Sakai; K Kondo; S Migita
Journal:  Jpn J Exp Med       Date:  1977-04

8.  Preparation of an alloantiserum to murine C3 and demonstration of multiple alleles.

Authors:  S Natsuume-Sakai; S Amano; J I Hayakawa; M Takahashi
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

9.  Structural polymorphism of murine factor B controlled by a locus closely linked to the H-2 complex and demonstration of multiple alleles.

Authors:  S Natsuume-Sakai; K Moriwaki; S Migita; K Sudo; K Suzuki; D Y Lu; C Wang; M Takahashi
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

10.  Structural polymorphism of murine complement factor H controlled by a locus located between the Hc and the beta 2M locus on the second chromosome of the mouse.

Authors:  S Natsuume-Sakai; K Sudoh; T Kaidoh; J Hayakawa; M Takahashi
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

View more
  2 in total

1.  C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients.

Authors:  Mohamed Jalloul Nsaiba; Marc Lapointe; Hajer Mabrouk; Wahiba Douki; Lotfi Gaha; Louis Pérusse; Claude Bouchard; Besma Bel Hadj Jrad; Katherine Cianflone
Journal:  Neurochem Res       Date:  2015-02-27       Impact factor: 3.996

2.  Molecular basis of polymorphisms of human complement component C3.

Authors:  M Botto; K Y Fong; A K So; C Koch; M J Walport
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.